How PD-L1 Biomarker Test Results Impact Clinical Management of Lung Cancer

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Goeffrey Oxnard and Lauren Ritterhouse review how the results of PD-L1 testing influence the choices in first- or second-line immunotherapy or combination immunochemotherapy in patients with squamous or non-squamous non-small-cell lung cancer.

September 20, 2013

Personalized Care and the Value Proposition

Linda Bosserman discusses the issues regarding the value of personalized care

October 14, 2014

System Burdens of Polycythemia Vera

Listen as Dr. Michaelis discusses the unique aspects of the system burdens of polycythemia vera, the difficult approach to treat and the options to treat.Supported through funding from Incyte